Journal of Pharmacological Sciences
Online ISSN : 1347-8648
Print ISSN : 1347-8613
ISSN-L : 1347-8613

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
Takuo SuzukiNorimasa TamehiroYoji SatoTetsu KobayashiAkiko Ishii-WatabeYouichi ShinozakiTomoko Nishimaki-MogamiToshihiro HashimotoYoshinori AsakawaKazuhide InoueYasuo OhnoTeruhide YamaguchiToru Kawanishi
著者情報
ジャーナル フリー 早期公開

論文ID: 08006FP

この記事には本公開記事があります。
詳細
抄録
Farnesoid X receptor (FXR) controls the expression of critical genes in bile acid and cholesterol homeostasis. To study FXR and to develop a regulator of cholesterol, some non-steroidal and steroidal ligands have been found in addition to endogenous ligands for FXR. In this study, we discovered five bile acid derivatives (methyl cholate, methyl deoxycholate, 5β-cholanic acid, 5β-cholanic acid-7α,12α-diol, and NIHS700) and two natural products (marchantin A and marchantin E) that activated FXR in the reporter assay. These compounds activated FXR to a high level comparable to the most potent endogenous bile acid, chenodeoxycholic acid, although it was not predicted from their structures; five of them were similar to the lower potency bile acids, and two were structurally much different from bile acids. The elevation levels of reporter gene expression by some of the screened compounds were varied in Cos-7, HepG2, HuH-7, and Caco-2 cells. These compounds also controlled the expression of genes regulated by FXR, and some of the compounds regulated these genes in a cell-type specific and/or gene-selective fashion. Therefore, molecular design of the compounds can cause selective modulation of the expression of FXR target genes.
著者関連情報
© The Japanese Pharmacological Society 2008
feedback
Top